Back to search
Cholestasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The present phase 1b/2 randomised, double-blind, placebo-controlled, two-part study is designed to evaluate the safety, tolerability, pharmacokinetic characteri…
The goal of this clinical trial is to learn whether adding calcitriol to vitamin D2 can improve vitamin D deficiency in children with cholestasis and chronic li…
In patients with Alagille syndrome (ALGS), the key objectives are to evaluate the tolerability, long-term safety (including possible liver toxicity) and long-te…
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the per…
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that c…
Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.
The primary objective of this open label extension study is to evaluate the long-term safety and tolerability of maralixibat.